The healthcare sector will continue to eclipse more of the economy over the next several years, with national healthcare expenditures hitting 19.4 percent of GDP by 2027, according to the Office of the Actuary at CMS. From 2018 to 2027, healthcare expenditures will grow an average of 5.5 percent annually, hitting nearly $6 trillion.

After acquiring Aetna for nearly $70 billion, CVS Health has taken a financial hit. During the three months ending Dec. 31, 2018, CVS Health lost $421 million in net income, according to its end-of-year financial results.

Paige.AI, a startup that uses AI to diagnose and treat cancer, announced the appointment of Leo Grady, PhD, as its new CEO and a member of its board of directors. Paige.AI was recently named a top startup in CB Insight's third annual AI 100 list.

The healthcare sector has been on fire over the last several years, with investors in the space seeing big returns on stocks. Even during periods of volatility across the stock market at the end of 2018, the healthcare sector remained consistent, with “stellar returns,” Bloomberg reported.

If some form of practice consolidation is in your radiology practice’s present or future, you should know that many tactical errors are made around the difficulty of sharing information across disparate legacy PACS packages and other peripheral solutions used by newly conjoining practices, departments or organizations. 

Thanks to an increasing demand of AI technology for research and drug development, the AI in healthcare market size is expected to exceed $13 billion by 2025, according to a report by Global Market Insights.

Anne Klibanski, MD, has been named interim president and CEO of Partners HealthCare. Klibanski’s current leadership responsibilities within the Partners system include research, academia and clinical work. She will succeed CEO David Torchiana, MD, who recently announced his plans to retire at the end of April. 

CMS has proposed covering a new form of cancer therapy, CAR T-cell therapy, under Medicare. The proposal would create a uniform standard of covering the treatment, which uses a patient’s own immune system to fight the disease.